Rapid Communication: Cu/Zn Superoxide Dismutase Activity in Familial and Sporadic Amyotrophic Lateral Sclerosis |
| |
Authors: | Wim Robberecht Peter Sapp Maria Kristina Viaene Daniel Rosen Dianne McKenna-Yasek Jonathan Haines Robert Horvitz Paul Theys Robert Brown Jr. |
| |
Affiliation: | Department of Neurology, University Hospital Gasthuisberg;Day Neuromuscular Research Laboratory, Massachusetts General Hospital, Charlestown;;Laboratory of Occupational Health, University of Leuven Medical School, Leuven, Belgium;;Molecular Neurogenetics Laboratory, Neuroscience Center, Massachusetts General Hospital, Boston;;Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge. Massachusetts. U.S.A. |
| |
Abstract: | ![]() Abstract: Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron disease that is inherited as an autosomal dominant trait in ~ 10% of cases. Recently we and others identified several single-base mutations in the Cu/Zn superoxide dismutase (SOD1) gene in patients with familial ALS (FALS). Using single-strand conformational polymorphism, we studied the C to G mutation in exon 2 of the SOD1 gene (resulting in a leucine to valine substitution in position 38) in affected and unaffected members of a large Belgian family with FALS. We measured the SOD1 activity in red blood cell lysates in 14 members of this family, including the only surviving clinically affected patient. SOD1 activity of the family members carrying the mutation was less than half that of members without the mutation. In addition, in 11 patients with sporadic ALS and 11 age- and sex-matched controls, red blood cell SOD1 activity was normal. These studies indicate that SOD1 activity is reduced in these FALS patients but not in sporadic ALS patients. Moreover, this SOD1 enzyme abnormality is detectable years before onset of clinical ALS in carriers of this FALS mutation. |
| |
Keywords: | Motor neuron disease Amyotrophic lateral sclerosis Superoxide dismutase Free radicals. |
|
|